Compare Cassava Sciences Inc (FLNA) vs Oatly Group AB - ADR (OTLY) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

OTLY trades at $9.97, up 2.15% today, with a bullish technical signal despite mixed moving averages. Revenue grew to $862M in 2025, but net losses persist at -$153M. The company maintains a strong brand presence, with recent product expansions in Canada and a partnership with Nespresso. Cash burn remains a concern, with negative operating cash flow of -$24M in 2025. Analyst consensus is divided, with 44% buy ratings but 50% hold, reflecting cautious optimism amid financial challenges.

Outlook: OTLY shows potential for growth through market expansion and cost management, but high debt and sustained losses pose significant risks. Investment appeal hinges on achieving profitability and reducing cash burn. Key catalysts include Q2 2026 earnings on July 22, 2026, and execution of strategic initiatives. Risks include liquidity constraints and competitive pressures in the plant-based beverage sector.